Research ArticleEpidemiology/Health Services Research
Open Access
Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study
Michael R. Rickels, Katrina J. Ruedy, Nicole C. Foster, Claude A. Piché, Hélène Dulude, Jennifer L. Sherr, William V. Tamborlane, Kathleen E. Bethin, Linda A. DiMeglio, R. Paul Wadwa, Andrew J. Ahmann, Michael J. Haller, Brandon M. Nathan, Santica M. Marcovina, Emmanouil Rampakakis, Linyan Meng, Roy W. Beck
DOI: 10.2337/dc15-1498 Published 1 February 2016
Michael R. Rickels
1University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
Katrina J. Ruedy
2Jaeb Center for Health Research, Tampa, FL
Nicole C. Foster
2Jaeb Center for Health Research, Tampa, FL
Claude A. Piché
3Locemia Solutions ULC, Montreal, QC, Canada
Hélène Dulude
3Locemia Solutions ULC, Montreal, QC, Canada
Jennifer L. Sherr
4Yale School of Medicine, New Haven, CT
William V. Tamborlane
4Yale School of Medicine, New Haven, CT
Kathleen E. Bethin
5Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, The State University of New York, Buffalo, NY
Linda A. DiMeglio
6Indiana University School of Medicine, Indianapolis, IN
R. Paul Wadwa
7Barbara Davis Center for Childhood Diabetes, Aurora, CO
Andrew J. Ahmann
8Harold Schnitzer Diabetes Health Center, Oregon Health & Science University, Portland, OR
Michael J. Haller
9University of Florida, Gainesville, FL
Brandon M. Nathan
10University of Minnesota, Minneapolis, MN
Santica M. Marcovina
11Northwest Lipid Metabolism and Diabetes Research Laboratories, Seattle, WA
Emmanouil Rampakakis
12JSS Medical Research, St. Laurent, QC, Canada
Linyan Meng
12JSS Medical Research, St. Laurent, QC, Canada
Roy W. Beck
2Jaeb Center for Health Research, Tampa, FL